MATA KULIAH | SKS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
3(3-0) | |
2(2-0) | |
3(3-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Total | 22 (20-2) |
MATA KULIAH | SKS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
Total | 22 (16-6) |
MATA KULIAH | SKS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Farmakoterapi Gangguan Imunologi, Hematologi dan Onkologi | 2(2-0) |
2(2-0) | |
Analisis Instrumen | 2(2-0) |
1(0-1) | |
2(2-0) | |
2(2-0) | |
Praktikum Formulasi dan Teknologi Sediaan Likuid dan Semisolid | 1(0-1) |
Total | 20 (16-4) |
MATA KULIAH | SKS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Kimia Medisinal | 2(2-0) |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Total | 20 (16-4) |
MATA KULIAH | SKS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
3(3-0) | |
3(3-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
3(3-0) | |
Total | 21 (19-2) |
MATA KULIAH | SKS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
3(3-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
1(0-1) | |
Total | 19 (15-4) |
MATA KULIAH | SKS |
Mata Kuliah Wajib:*) | |
4(0-4) | |
Mata Kuliah Pilihan:*) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Penanganan Penyalahgunaan Obat dan Penatalaksanaan Keracunan | 2(2-0) |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Total | 18 (14-4)* |
*) 4 SKS dari Mata Kuliah Wajib dan 14 SKS dari Mata Kuliah Pilihan
MATA KULIAH | SKS |
1(0-1) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Total | 8 (6-2) |